OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Next generation radiotheranostics promoting precision medicine
Kelsey L. Pomykala, Boris Hadaschik, Oliver Sartor, et al.
Annals of Oncology (2023) Vol. 34, Iss. 6, pp. 507-519
Open Access | Times Cited: 37
Kelsey L. Pomykala, Boris Hadaschik, Oliver Sartor, et al.
Annals of Oncology (2023) Vol. 34, Iss. 6, pp. 507-519
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Advances and challenges in precision imaging
Hedvig Hricak, Marius E. Mayerhoefer, Ken Herrmann, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 1, pp. e34-e45
Closed Access | Times Cited: 3
Hedvig Hricak, Marius E. Mayerhoefer, Ken Herrmann, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 1, pp. e34-e45
Closed Access | Times Cited: 3
Advances in Radioligand Theranostics in Oncology
Ismaheel O. Lawal, Sofiullah Abubakar, Honest Ndlovu, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 3, pp. 265-289
Closed Access | Times Cited: 11
Ismaheel O. Lawal, Sofiullah Abubakar, Honest Ndlovu, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 3, pp. 265-289
Closed Access | Times Cited: 11
Fibroblast Activation Protein Inhibitor Tracers and Their Preclinical, Translational, and Clinical Status in China
Liang Zhao, Fei Kang, Yizhen Pang, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. Supplement 1, pp. 4S-11S
Closed Access | Times Cited: 9
Liang Zhao, Fei Kang, Yizhen Pang, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. Supplement 1, pp. 4S-11S
Closed Access | Times Cited: 9
Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update
Martina Di Franco, Lucia Zanoni, Emilia Fortunati, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 538-550
Open Access | Times Cited: 8
Martina Di Franco, Lucia Zanoni, Emilia Fortunati, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 538-550
Open Access | Times Cited: 8
Radiotherapeutics, clonal hematopoiesis, and risk of hematologic malignancies: The good, the bad, the ugly
Catherine H. Marshall, Emmanuel S. Antonarakis, Mrinal M. Patnaik
Blood Reviews (2025), pp. 101269-101269
Closed Access | Times Cited: 1
Catherine H. Marshall, Emmanuel S. Antonarakis, Mrinal M. Patnaik
Blood Reviews (2025), pp. 101269-101269
Closed Access | Times Cited: 1
Expanding horizons in theragnostics: from oncology to multidisciplinary applications
Ruicheng Wu, Weizhen Zhu, Fanglin Shao, et al.
La radiologia medica (2025)
Closed Access | Times Cited: 1
Ruicheng Wu, Weizhen Zhu, Fanglin Shao, et al.
La radiologia medica (2025)
Closed Access | Times Cited: 1
Guardians of precision: advancing radiation protection, safety, and quality systems in nuclear medicine
Francesco Giammarile, Peter Knoll, Jolanta Kunikowska, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 6, pp. 1498-1505
Open Access | Times Cited: 6
Francesco Giammarile, Peter Knoll, Jolanta Kunikowska, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 6, pp. 1498-1505
Open Access | Times Cited: 6
Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication
Margarita Kirienko, Fabrizia Gelardi, Francesco Fiz, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Open Access | Times Cited: 6
Margarita Kirienko, Fabrizia Gelardi, Francesco Fiz, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Open Access | Times Cited: 6
Recent advances of nanocrystals in cancer theranostics
Devyani Yenurkar, Malay Nayak, Sudip Mukherjee
Nanoscale Advances (2023) Vol. 5, Iss. 16, pp. 4018-4040
Open Access | Times Cited: 11
Devyani Yenurkar, Malay Nayak, Sudip Mukherjee
Nanoscale Advances (2023) Vol. 5, Iss. 16, pp. 4018-4040
Open Access | Times Cited: 11
Effect of Linker Entities on Pharmacokinetics of 111In-Labeled Prostate-Specific Membrane Antigen-Targeting Ligands with an Albumin Binder
Nobuki Kazuta, Kazuma Nakashima, Hiroyuki Watanabe, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2401-2413
Closed Access | Times Cited: 4
Nobuki Kazuta, Kazuma Nakashima, Hiroyuki Watanabe, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2401-2413
Closed Access | Times Cited: 4
Oral Antioxidant-Engineered Probiotics for the Treatment of Radiation-Induced Colitis
Rong Sun, Shuaiwen Li, Zihui Chen, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Rong Sun, Shuaiwen Li, Zihui Chen, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
A study of differences in absorbed dose estimates by images used in dosimetry of Lu-177-DOTATATE therapy
Y Masaki, Yasuo Yamashita, Takuro Isoda, et al.
Radiological Physics and Technology (2025)
Closed Access
Y Masaki, Yasuo Yamashita, Takuro Isoda, et al.
Radiological Physics and Technology (2025)
Closed Access
Targeting the tumour cell surface in advanced prostate cancer
Cristina Boixareu, Tarek Taha, Varadha Balaji Venkadakrishnan, et al.
Nature Reviews Urology (2025)
Closed Access
Cristina Boixareu, Tarek Taha, Varadha Balaji Venkadakrishnan, et al.
Nature Reviews Urology (2025)
Closed Access
Dual-targeted alpha therapy mitigates prostate cancer and boosts immune checkpoint blockade therapy
Juan Sun, Jiangtao Yang, Jiakun Guo, et al.
Journal of Controlled Release (2025), pp. 113686-113686
Closed Access
Juan Sun, Jiangtao Yang, Jiakun Guo, et al.
Journal of Controlled Release (2025), pp. 113686-113686
Closed Access
Development of Stimuli-Responsive Polymeric Nanomedicines in Hypoxic Tumors and Their Therapeutic Promise in Oral Cancer
Jialong Hou, Zhijun Xue, Yao Chen, et al.
Polymers (2025) Vol. 17, Iss. 8, pp. 1010-1010
Open Access
Jialong Hou, Zhijun Xue, Yao Chen, et al.
Polymers (2025) Vol. 17, Iss. 8, pp. 1010-1010
Open Access
Nuclear Medicine and Cancer Theragnostics: Basic Concepts
Vasiliki Zoi, Maria Giannakopoulou, George Α. Alexiou, et al.
Diagnostics (2023) Vol. 13, Iss. 19, pp. 3064-3064
Open Access | Times Cited: 9
Vasiliki Zoi, Maria Giannakopoulou, George Α. Alexiou, et al.
Diagnostics (2023) Vol. 13, Iss. 19, pp. 3064-3064
Open Access | Times Cited: 9
Comparative Study of the Effect of Radiation Delivered by Lutetium-177 or Actinium-225 on Anti-GD2 Chimeric Antigen Receptor T Cell Viability and Functions
Quaovi H. Sodji, Matthew H. Forsberg, Dan Cappabianca, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 191-191
Open Access | Times Cited: 9
Quaovi H. Sodji, Matthew H. Forsberg, Dan Cappabianca, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 191-191
Open Access | Times Cited: 9
Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy?
Janke Kleynhans, Thomas Ebenhan, Frederik Cleeren, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 7, pp. 1965-1980
Open Access | Times Cited: 3
Janke Kleynhans, Thomas Ebenhan, Frederik Cleeren, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 7, pp. 1965-1980
Open Access | Times Cited: 3
PDCdb: the biological activity and pharmaceutical information of peptide–drug conjugate (PDC)
Xiuna Sun, Hanyang Li, Zhen Chen, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1476-D1485
Open Access | Times Cited: 3
Xiuna Sun, Hanyang Li, Zhen Chen, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1476-D1485
Open Access | Times Cited: 3
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose–response and threshold absorbed doses
Jean‐Pierre Pouget, Pablo Mínguez Gabiña, Ken Herrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Open Access | Times Cited: 3
Jean‐Pierre Pouget, Pablo Mínguez Gabiña, Ken Herrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Open Access | Times Cited: 3
Nuclear Medicine and Cancer Theragnostics
Vasiliki Zoi, Maria Giannakopoulou, George Α. Alexiou, et al.
(2023)
Open Access | Times Cited: 7
Vasiliki Zoi, Maria Giannakopoulou, George Α. Alexiou, et al.
(2023)
Open Access | Times Cited: 7
Human Serum Albumin‐Coated 10B Enriched Carbon Dots as Targeted “Pilot Light” for Boron Neutron Capture Therapy
Tianyuan Zhong, Yongjin Yang, Miao Pang, et al.
Advanced Science (2024) Vol. 11, Iss. 43
Open Access | Times Cited: 2
Tianyuan Zhong, Yongjin Yang, Miao Pang, et al.
Advanced Science (2024) Vol. 11, Iss. 43
Open Access | Times Cited: 2
Novel Radiotheranostic Ligands Targeting Prostate-Specific Membrane Antigen Based on Dual Linker Approach
Nobuki Kazuta, Kazuma Nakashima, Yuta Tarumizu, et al.
Molecular Pharmaceutics (2024) Vol. 22, Iss. 1, pp. 377-386
Closed Access | Times Cited: 2
Nobuki Kazuta, Kazuma Nakashima, Yuta Tarumizu, et al.
Molecular Pharmaceutics (2024) Vol. 22, Iss. 1, pp. 377-386
Closed Access | Times Cited: 2
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers
Martina Sollini, Jérémie Calais, Arturo Chiti, et al.
European Urology (2024)
Closed Access | Times Cited: 1
Martina Sollini, Jérémie Calais, Arturo Chiti, et al.
European Urology (2024)
Closed Access | Times Cited: 1
Development of Radiolabeled Probes with Improved Imaging Contrast by Releasing Urinary Excretable Radiolabeled Compounds from Thermosensitive Liposomes in the Blood
Masayuki Munekane, Masanobu Ozaki, Yusuke Mitani, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 1
Masayuki Munekane, Masanobu Ozaki, Yusuke Mitani, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 1
